Appointments and advancements
Wednesday, February 5, 2014
Novogen Ltd., of Sydney, named Justine Stehn director of the anti-tropomyosin (ATM) program, and appointed Peter Gunning to its scientific advisory panel for ATM technology.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.